Each year, Baylor College of Medicine faculty are recognized for their outstanding published scientific contributions to clinical and basic science research over the past three years through the Michael E. DeBakey M.D. Award for Excellence in Research. This years 2022 recipients are Dr
Zhang wins $11.2 million NIH PPG grant to improve heart attack recovery through growth of new heart muscle cells. Jianyi Jay Zhang, M.D., Ph.D.The National Institutes of Health has awarded a five-year, $11.2 million program project grant, or PPG, to Jianyi Jay Zhang, M.D., Ph.D., and colleagues to study how to restore the dead tissue from a heart attack, through the growth of new heart muscle cells. That is a challenge because mammalian hearts show almost no ability to grow new heart muscle cells, called cardiomyocytes, after birth. After a heart attack from a blocked artery, the dead tissue is not repaired with new cardiomyocytes
Westford, USA, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Multiple myeloma is a cancer of plasma cells in the bone marrow. It is the most common type of leukemia, and the fifth most common cancer around the globe. Prevalence rates of multiple myeloma have more than doubled over the past 30 years and continue to increase, reaching an all-time high of 1.3 million people in 2021. As per SkyQuest analysis of the Multiple Myeloma market, the global prevalence of multiple myeloma is currently pegged at 0.7%, which translates to around 1 case in 132 individuals
Chicago, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cell Therapy Technologies Marketis projected to grow from USD 4.0 billion in 2022 to USD 8.0 billion by 2027, at a CAGR of 14.6% from 2022 to 2027, according to a new report by MarketsandMarkets. Growth in the market can be attributed to number of cell therapy clinical trials related to cancer. Furthermore, increasing incidence of communicable diseases and the growing risk of pandemics are also expected to fuel the market growth
MarketsandMarkets Research Pvt. Ltd.
Space is undergoing a revolution in access and attainability and may soon cease to be a distant frontier visited only by the select few. The past several years have brought about dozens of milestones in civilian space travel. In 2021 alone, a film crew visited the ISS, Blue Origin and Virgin Galactic completed successful suborbital trips and the first crewed orbital mission without astronauts was achieved.
DUBLIN--(BUSINESS WIRE)--The "Stem Cell Therapy Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. The global stem cell therapy market reached a value of nearly $4,019.6 million in 2021, having increased at a compound annual growth rate (CAGR) of 70.9% since 2016. The market is expected to grow from $4,019.6 million in 2021 to $10,600.2 million in 2026 at a rate of 21.4%
image:Microglia (in green) in a sea of different excitatory neuron types (colored red or blue). A new study shows how microglia are prompted to change their state to adapt to different areas of the brain. view more Credit: Arlotta Lab From everyday actions like walking and talking to feats of athletic or academic excellence, the brain is constantly acquiring and seamlessly processing information to produce these incredible behaviors.
Medium recently highlighted University of Cincinnati research thatshows early indications that light can be used as a treatment for certain diseases, including cancer. Jiajie Diao, PhD,associate professor in the Department of Cancer Biology in UCs College of Medicine and a University of Cincinnati Cancer Center member, and colleagues at the University of Illinois Urbana-Champaign and the University at Buffalo published the results of their study demonstrating light-activated proteins can help normalize dysfunction within cells in the journal Nature Communications July 25. The researchers attached two separate proteins to mitochondria and lysosomes within stem cells. When stimulated by blue light, the proteins naturally bind to each other to form one new protein, which also brings the mitochondria and lysosome into contact. Once they are brought together, the lysosome can cut the mitochondria, achieving fission
A team at the University of California, Irvine, has identified a signaling molecule that potently stimulates hair growth. A signaling molecule known as SCUBE3, which was discovered by researchers at the University of California, Irvine, has the potential to cure androgenetic alopecia, a prevalent type of hair loss in both women and men. The research, which was recently published in the journal Developmental Cell, uncovered the precise mechanism by which the dermal papilla cells, specialized signal-producing fibroblasts found at the bottom of each hair follicle, encourage new development. Although the critical role dermal papilla cells play in regulating hair growth is widely established, the genetic basis of the activating chemicals involved is little understood. There is a strong need for new, effective hair loss medicines, and naturally occurring compounds that are normally used by the dermal papilla cells present ideal next-generation candidates for treatment, says Maksim Plikus, Ph.D., UCI professor of developmental and cell biology and the studys corresponding author
Recent Comments